These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26745037)

  • 1. Potential Roles of Protease Inhibitors in Cancer Progression.
    Yang P; Li ZY; Li HQ
    Asian Pac J Cancer Prev; 2015; 16(18):8047-52. PubMed ID: 26745037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of protease and protease inhibitors in cancer pathogenesis and treatment.
    Eatemadi A; Aiyelabegan HT; Negahdari B; Mazlomi MA; Daraee H; Daraee N; Eatemadi R; Sadroddiny E
    Biomed Pharmacother; 2017 Feb; 86():221-231. PubMed ID: 28006747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiprotease therapy in cancer: hot or not?
    Lah TT; Durán Alonso MB; Van Noorden CJ
    Expert Opin Biol Ther; 2006 Mar; 6(3):257-79. PubMed ID: 16503735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting proteases: successes, failures and future prospects.
    Turk B
    Nat Rev Drug Discov; 2006 Sep; 5(9):785-99. PubMed ID: 16955069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities.
    Song R; Qiao W; He J; Huang J; Luo Y; Yang T
    J Med Chem; 2021 Mar; 64(6):2851-2877. PubMed ID: 33656892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proteases in cancer progression].
    Flores-Reséndiz D; Castellanos-Juárez E; Benítez-Bribiesca L
    Gac Med Mex; 2009; 145(2):131-42. PubMed ID: 19518020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular proteases as targets for treatment of cancer metastases.
    Lee M; Fridman R; Mobashery S
    Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do proteases play a role in cancer invasion and metastasis?
    Duffy MJ
    Eur J Cancer Clin Oncol; 1987 May; 23(5):583-9. PubMed ID: 3308476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Compounds as Protease Inhibitors in Therapeutic Focus on Cancer Therapy.
    Kakali B
    Anticancer Agents Med Chem; 2024; 24(16):1167-1181. PubMed ID: 38988167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Based Delivery of Protease Inhibitors to Cancer Cells.
    Prunk M; Kos J
    Curr Med Chem; 2017; 24(42):4816-4837. PubMed ID: 27667137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of proteases in tumour suppression.
    López-Otín C; Matrisian LM
    Nat Rev Cancer; 2007 Oct; 7(10):800-8. PubMed ID: 17851543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy.
    Rudzińska M; Daglioglu C; Savvateeva LV; Kaci FN; Antoine R; Zamyatnin AA
    Drug Des Devel Ther; 2021; 15():9-20. PubMed ID: 33442233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitors.
    Lahlil R; Calvo F; Khatib AM
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):83-91. PubMed ID: 19149690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteases as anti-cancer targets--molecular and biological basis for development of inhibitor-like drugs against cancer.
    Białas A; Kafarski P
    Anticancer Agents Med Chem; 2009 Sep; 9(7):728-62. PubMed ID: 19538170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of proteases as anticancer drugs.
    Jedinak A; Maliar T
    Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The metalloproteinases in cancer].
    Noël A; Foidart JM
    Bull Mem Acad R Med Belg; 2005; 160(10-12):417-24; discussion 424-5. PubMed ID: 16768246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis.
    Radisky ES
    J Biol Chem; 2024 Jun; 300(6):107347. PubMed ID: 38718867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional imaging of tumor proteolysis.
    Sloane BF; Sameni M; Podgorski I; Cavallo-Medved D; Moin K
    Annu Rev Pharmacol Toxicol; 2006; 46():301-15. PubMed ID: 16402907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases. Novel targets for directed cancer therapy.
    Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
    Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Peptidome and Tumor-Resident Proteolysis.
    Fan J; Ning B; Lyon CJ; Hu TY
    Enzymes; 2017; 42():1-25. PubMed ID: 29054266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.